Hematology TimesTeam targets transcription factor in AMLMarch 9, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsMEC plus ixazomib looks promising in relapsed/refractory AMLMarch 8, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsGCLAM therapy shows promise for relapsed/refractory AMLMarch 6, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesHSCT approach provides ‘excellent’ survival in FAMarch 2, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLMyelodysplastic Syndrome
Hematology TimesCHMP recommends approval for GO in AMLMarch 1, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesExpanded UCB product can stand aloneFebruary 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAMLALLMyelodysplastic Syndrome
Hematology NewsTamibarotene shows strong results in high-risk APL patientsFebruary 20, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA grants ivosidenib NDA priority reviewFebruary 17, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesNK-cell therapy in resistant MDS, AMLFebruary 16, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesAzacitidine now available in ChinaFebruary 9, 2018AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
Hematology NewsAML immune profiles correlate with relapse-free survivalFebruary 4, 2018AMLImmunotherapyLeukemia, Myelodysplasia, Transplantation
Hematology NewsmIDH inhibitors could fill treatment gap in AMLJanuary 25, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesEC grants orphan designation to gilteritinib for AMLJanuary 24, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsRELAZA2: MRD-guided azacitidine reduces relapse risk in MDS and AMLJanuary 21, 2018Myelodysplastic SyndromeAMLLeukemia, Myelodysplasia, Transplantation
